Welcome to the Oximmuno Blog
10 July 2020
OxImmuno
OxImmuno Literature Blog - COVID-19 research papers explained simply
Welcome to the brand new OxImmuno Literature Blog.
We are a group of research students and early career researchers in the Medical Sciences Division who are voluntarily reading and reviewing some of the most recent immunology-focussed COVID-19 research. The OxImmuno Literature initiative has collected together a team of around 100 researchers from the Medical Sciences Division of the University of Oxford to read, review and summarise recent COVID-19 research from all round the world in order to support the researchers working on COVID-19 here at the University of Oxford.
Research papers are peer reviewed, ie read and checked by other scientists, before they are published in research journals. As COVID-19 is such a new phenomenon most of the research has not yet had time to be peer reviewed but, in order to help other scientists working on COVID-19, research is still made available as a pre-print for other researchers to read.
Our summaries of some of these pre-prints and papers can be read here. However, these are written for other researchers. We have selected a few papers that cover topics in COVID-19 research that we think may be of interest to the wider public and have summarised them for a more general audience and included more background information. These summaries, with links to the original research, can be found in this, our new blog.
These summaries are created by researchers in the OxImmuno Literature initiative and are simplified views which are meant to help to explain the concept/ideas behind the research papers and not every single detail. They should not be considered as an endorsement or otherwise of the research.
What to read next
Oximmuno - Meet the team (1)
10 July 2020
Meet the authors of the Diabetes and COVID-19 blog post - Elizabeth Mann, Barbora Schonfeldova, Max Quastel, Mathilde Pohin, & Athena Cavounidis
Diabetes and COVID-19
10 July 2020
Why are diabetics at high risk of suffering particularly severe responses to viruses such as SARS-CoV-2 which causes COVID-19?